Cargando…

Combined influence of illness duration and medication type on visual sensitivity in schizophrenia

OBJECTIVE: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Natalia L., Fernandes, Thiago P., Lima, Eveline H., Sales, Hemerson F., Santos, Natanael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986493/
https://www.ncbi.nlm.nih.gov/pubmed/31269094
http://dx.doi.org/10.1590/1516-4446-2018-0331
_version_ 1783491970306408448
author Almeida, Natalia L.
Fernandes, Thiago P.
Lima, Eveline H.
Sales, Hemerson F.
Santos, Natanael A.
author_facet Almeida, Natalia L.
Fernandes, Thiago P.
Lima, Eveline H.
Sales, Hemerson F.
Santos, Natanael A.
author_sort Almeida, Natalia L.
collection PubMed
description OBJECTIVE: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function. METHODS: Data were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings. RESULTS: Patients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years. CONCLUSION: Visual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms.
format Online
Article
Text
id pubmed-6986493
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Associação Brasileira de Psiquiatria
record_format MEDLINE/PubMed
spelling pubmed-69864932020-01-29 Combined influence of illness duration and medication type on visual sensitivity in schizophrenia Almeida, Natalia L. Fernandes, Thiago P. Lima, Eveline H. Sales, Hemerson F. Santos, Natanael A. Braz J Psychiatry Original Article OBJECTIVE: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function. METHODS: Data were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings. RESULTS: Patients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years. CONCLUSION: Visual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms. Associação Brasileira de Psiquiatria 2019-07-01 /pmc/articles/PMC6986493/ /pubmed/31269094 http://dx.doi.org/10.1590/1516-4446-2018-0331 Text en http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Almeida, Natalia L.
Fernandes, Thiago P.
Lima, Eveline H.
Sales, Hemerson F.
Santos, Natanael A.
Combined influence of illness duration and medication type on visual sensitivity in schizophrenia
title Combined influence of illness duration and medication type on visual sensitivity in schizophrenia
title_full Combined influence of illness duration and medication type on visual sensitivity in schizophrenia
title_fullStr Combined influence of illness duration and medication type on visual sensitivity in schizophrenia
title_full_unstemmed Combined influence of illness duration and medication type on visual sensitivity in schizophrenia
title_short Combined influence of illness duration and medication type on visual sensitivity in schizophrenia
title_sort combined influence of illness duration and medication type on visual sensitivity in schizophrenia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986493/
https://www.ncbi.nlm.nih.gov/pubmed/31269094
http://dx.doi.org/10.1590/1516-4446-2018-0331
work_keys_str_mv AT almeidanatalial combinedinfluenceofillnessdurationandmedicationtypeonvisualsensitivityinschizophrenia
AT fernandesthiagop combinedinfluenceofillnessdurationandmedicationtypeonvisualsensitivityinschizophrenia
AT limaevelineh combinedinfluenceofillnessdurationandmedicationtypeonvisualsensitivityinschizophrenia
AT saleshemersonf combinedinfluenceofillnessdurationandmedicationtypeonvisualsensitivityinschizophrenia
AT santosnatanaela combinedinfluenceofillnessdurationandmedicationtypeonvisualsensitivityinschizophrenia